Literature DB >> 2227421

Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions.

M C Longo1, M S Berninger, J L Hartley.   

Abstract

Polymerase chain reactions (PCRs) synthesize abundant amplification products. Contamination of new PCRs with trace amounts of these products, called carry-over contamination, yields false positive results. Carry-over contamination from some previous PCR can be a significant problem, due both to the abundance of PCR products, and to the ideal structure of the contaminant material for re-amplification. We report that carry-over contamination can be controlled by the following two steps: (i) incorporating dUTP in all PCR products (by substituting dUPT for dTTP, or by incorporating uracil during synthesis of the oligodeoxyribonucleotide primers; and (ii) treating all subsequent fully preassembled starting reactions with uracil DNA glycosylase (UDG), followed by thermal inactivation of UDG. UDG cleaves the uracil base from the phosphodiester backbone of uracil-containing DNA, but has no effect on natural (i.e., thymine-containing) DNA. The resulting apyrimidinic sites block replication by DNA polymerases, and are very labile to acid/base hydrolysis. Because UDG does not react with dUTP, and is also inactivated by heat denaturation prior to the actual PCR, carry-over contamination of PCRs can be controlled effectively if the contaminants contain uracils in place of thymines.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2227421     DOI: 10.1016/0378-1119(90)90145-h

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  227 in total

Review 1.  Molecular diagnosis of herpes simplex virus infections in the central nervous system.

Authors:  Y W Tang; P S Mitchell; M J Espy; T F Smith; D H Persing
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  A multilocus genotyping assay for candidate markers of cardiovascular disease risk.

Authors:  S Cheng; M A Grow; C Pallaud; W Klitz; H A Erlich; S Visvikis; J J Chen; C R Pullinger; M J Malloy; G Siest; J P Kane
Journal:  Genome Res       Date:  1999-10       Impact factor: 9.043

3.  Evaluation of three commercial detection systems for Mycobacterium tuberculosis where clinical diagnosis is difficult.

Authors:  T J Brown; E G Power; G L French
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

4.  Transcript quantitation in total yeast cellular RNA using kinetic PCR.

Authors:  J J Kang; R M Watson; M E Fisher; R Higuchi; D H Gelfand; M J Holland
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

5.  Single-tube balanced heminested PCR for detecting Mycobacterium tuberculosis in smear-negative samples.

Authors:  A García-Quintanilla; L Garcia; G Tudó; M Navarro; J González; M T Jiménez de Anta
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

6.  Signal amplification through nucleotide extension and excision on a dendritic DNA platform.

Authors:  S Capaldi; R C Getts; S D Jayasena
Journal:  Nucleic Acids Res       Date:  2000-04-01       Impact factor: 16.971

7.  High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR.

Authors:  S Germer; M J Holland; R Higuchi
Journal:  Genome Res       Date:  2000-02       Impact factor: 9.043

8.  Clinically applicable multiplex PCR for four middle ear pathogens.

Authors:  P H Hendolin; L Paulin; J Ylikoski
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

Review 9.  PCR in diagnosis of infection: detection of bacteria in cerebrospinal fluids.

Authors:  Yoshimasa Yamamoto
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

Review 10.  Molecular diagnostics in preimplantation genetic diagnosis.

Authors:  Alan R Thornhill; Karen Snow
Journal:  J Mol Diagn       Date:  2002-02       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.